Abstract
In obesity, the pathological remodeling of adipose tissue (AT)—characterized by hyperplasia and hypertrophy—serves as a critical hub driving chronic inflammation. This process triggers adipose microenvironment disruption, manifesting as reduced angiogenesis, excessive extracellular matrix deposition, dysregulated adipokine secretion, and enhanced immune cell infiltration, ultimately leading to a systemic low-grade inflammatory state. Functioning as an active inflammatory organ, dysfunctional adipose tissue specifically exacerbates periodontitis progression through multiple mechanisms: including glucose/lipid metabolic imbalance, dysregulated bone metabolism with imbalanced osteoclast-osteoblast activity, immunometabolic disturbances, microcirculatory impairment, degradation of periodontal extracellular matrix and dysfunction of epithelial barrier and gut microbiota dysbiosis. This review systematically elucidates the interactive mechanisms between adipose tissue-derived inflammatory signaling and periodontal pathology, emphasizing its central role in obesity-associated periodontal diseases. Based on these mechanisms, we propose targeted intervention strategies: modulating adipokine secretion, suppressing immune cell infiltration in adipose tissue or restoring adipose tissue metabolic homeostasis may emerge as novel approaches to disrupt the obesity-periodontitis vicious cycle.
Introduction: The "Sick Fat" Factory
Periodontitis and obesity are two of the most prevalent chronic conditions globally. While epidemiological data has long shown they are linked, the underlying biological "handshake" between the two has remained complex. Historically, adipose tissue (AT) was viewed as a passive energy reservoir. However, in the state of obesity, AT undergoes pathological remodeling (hypertrophy and hyperplasia), transforming into a dysfunctional endocrine organ. This "sick fat" sends systemic inflammatory signals that exacerbate the destruction of periodontal tissues, including the gums and the alveolar bone that supports teeth.
Methodology
This review systematically synthesizes clinical and experimental literature across several domains:
- Molecular Biology: Examining adipokine signaling (leptin, adiponectin, resistin).
- Immunology: Mapping the shift from anti-inflammatory (M2) to pro-inflammatory (M1) macrophage dominance in fat depots.
- Clinical Epidemiology: Analyzing data from large-scale health surveys like NHANES III.
- Systems Biology: Proposing a "Gut-AT-Periodontitis Axis" to explain how diet and microbiota influence this systemic cycle.
Key Mechanisms of Periodontal Destruction
The Adipose-Bone Axis
Adipose tissue is a significant source of multipotent mesenchymal stem cells (MSCs). In obesity, the competitive differentiation of these cells shifts: they are "pushed" to become more fat cells (adipogenesis) rather than bone-forming cells (osteogenesis), directly impairing the body's ability to repair the jawbone.
Adipokine Imbalance and Matrix Degradation
A critical flip in chemical signaling occurs in dysfunctional fat. Healthy fat produces Adiponectin, which protects bone and reduces inflammation. Obese fat overproduces Leptin and Resistin, which trigger bone-eating cells (osteoclasts) and upregulate Matrix Metalloproteinases (MMPs) that degrade the periodontal extracellular matrix (ECM) and destroy the epithelial barrier.
Microcirculatory Impairment
Perivascular Adipose Tissue (fat surrounding blood vessels) becomes inflamed, leading to microcirculatory impairment in the gums. This starves the periodontal tissue of oxygen and nutrients, making it more susceptible to infection and less capable of healing.
Clinical Results and Implications
- Risk Multiplication: Obese individuals are 2 to 3 times more likely to develop periodontitis, independent of traditional risk factors like age or smoking.
- Systemic Load: Adipose tissue in obese individuals can contribute up to 50% of circulating Interleukin-6 (IL-6), a key driver of systemic low-grade inflammation.
- Bidirectional Cycle: The relationship is a "vicious cycle." While obesity worsens gum disease, periodontal infections can exacerbate systemic insulin resistance and dyslipidemia, further damaging metabolic health.
Future Directions
The authors call for "multi-organ" treatment strategies. Future work should explore whether targeting adipose-specific immune pathways (e.g., modulating adipokine secretion) can serve as a viable adjunct to traditional scaling and root planing. Additionally, the use of Adipose-derived Stem Cells (ASCs) for periodontal regeneration remains a promising frontier for clinical translation.
Summary updated